Voloridge Investment Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-73,127
Closed -$939K 1335
2025
Q3
$939K Buy
+73,127
New +$975K ﹤0.01% 1048
2023
Q1
Sell
-248,155
Closed -$3.32M 1587
2022
Q4
$3.32M Sell
248,155
-92,041
-27% -$1.19M 0.02% 808
2022
Q3
$4.05M Sell
340,196
-370,923
-52% -$5.27M 0.02% 725
2022
Q2
$9.05M Buy
711,119
+122,902
+21% +$1.58M 0.05% 475
2022
Q1
$7.6M Buy
588,217
+121,927
+26% +$1.61M 0.04% 498
2021
Q4
$7.39M Buy
466,290
+380,212
+442% +$6.49M 0.04% 563
2021
Q3
$1.68M Sell
86,078
-229,668
-73% -$4.56M 0.01% 1106
2021
Q2
$7.19M Buy
315,746
+67,009
+27% +$1.39M 0.05% 514
2021
Q1
$4.57M Buy
+248,737
New +$4.08M 0.03% 555
2020
Q4
Sell
-123,901
Closed -$1.39M 1541
2020
Q3
$1.39M Sell
123,901
-145,345
-54% -$1.43M 0.01% 835
2020
Q2
$2.14M Buy
269,246
+174,074
+183% +$1.44M 0.02% 595
2020
Q1
$769K Buy
+95,172
New +$1.13M 0.02% 584
2019
Q2
Sell
-70,485
Closed -$535K 1031
2019
Q1
$535K Buy
+70,485
New +$567K 0.02% 643

Other funds holding SEM

Voloridge Investment Management's SEM Position: Q4 2025 in Review

Voloridge Investment Management sold out of Select Medical (SEM) in Q4 2025, closing a stake of 73,127 shares — an estimated $939K sold.

Voloridge Investment Management first reported a position in SEM in Q1 2019 and held it in 13 quarters. The position peaked at $9.05M in Q2 2022. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

  • Voloridge Investment Management reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 73,127 Select Medical shares in Q4 2025, an estimated $939K.
  • Voloridge Investment Management first reported a position in Select Medical in Q1 2019 and held it in 13 quarters.
  • Voloridge Investment Management's Select Medical position peaked at $9.05M in Q2 2022.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.